Urovant Sciences Ltd.(UROV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

UROV Urovant Sciences Ltd.

停牌 03-26 16:00:00 EDT

16.24

+0.00

0.00%

最高16.24	最低16.24	成交量0.00
今开16.24	昨收16.24	日振幅0.00%
总市值5.32亿	流通市值1.07亿	总股本3,274万
成交额0.00	换手率0.00%	流通股本661.20万
市净率-3.65	ROE218.18%	每股收益-5.25
52周最高16.26	52周最低7.15	市盈率-3.09
股息0.00	股息收益率0.00	ROA-75.13%

北京优虎网络科技有限公司

{"stockData":{"symbol":"UROV","market":"US","secType":"STK","nameCN":"Urovant Sciences Ltd.","latestPrice":16.24,"timestamp":1616788800000,"preClose":16.24,"halted":3,"volume":0,"delay":0,"floatShares":6612018,"shares":32743396,"eps":-5.253893,"marketStatus":"停牌","change":0,"latestTime":"03-26 16:00:00 EDT","open":16.24,"high":16.24,"low":16.24,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.253893,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1756800000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1538020800000,"exchange":"NASDAQ","adjPreClose":16.24,"volumeRatio":0},"requestUrl":"/m/hq/s/UROV","defaultTab":"news","newsList":[],"profile":{"websiteUrl":"http://www.urovant.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":0.0167},{"period":"3month","weight":0.0944},{"period":"6month","weight":0.0856},{"period":"1year","weight":0.1553},{"period":"ytd","weight":0.1006}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Urovant Sciences Ltd.是一家根据百慕达法律于2016年1月27日以Roivant PPS Holdings Ltd.名义注册成立的豁免有限公司。公司于2016年11月14日更名为Thalavant Sciences Ltd.并向Urovant Sciences Ltd.出售。Urovant Sciences是一家临床阶段的生物制药公司，致力于为泌尿系统疾病开发和商业化创新疗法。他们的候选产品vibegron是一种口服，每日一次的小分子，根据体外数据，是一种有效且高度选择性的β-3激动剂。Vibegron目前正在开发用于三种潜在适应症：膀胱过度活动症（OAB），良性前列腺增生或BPH男性的OAB治疗以及肠易激综合症或IBS引起的腹痛治疗。该公司的第二个候选产品URO-902是一种新型基因疗法，是该公司正在为口服药物治疗失败的OAB患者开发的一种新型基因疗法。","exchange":"NASDAQ","name":"Urovant Sciences Ltd.","nameEN":"Urovant Sciences Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Urovant Sciences Ltd.(UROV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Urovant Sciences Ltd.(UROV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Urovant Sciences Ltd.,UROV,Urovant Sciences Ltd.股票,Urovant Sciences Ltd.股票老虎,Urovant Sciences Ltd.股票老虎国际,Urovant Sciences Ltd.行情,Urovant Sciences Ltd.股票行情,Urovant Sciences Ltd.股价,Urovant Sciences Ltd.股市,Urovant Sciences Ltd.股票价格,Urovant Sciences Ltd.股票交易,Urovant Sciences Ltd.股票购买,Urovant Sciences Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Urovant Sciences Ltd.(UROV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Urovant Sciences Ltd.(UROV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}